Home > Portfolio
Current investments
Skyline Diagnostics B.V.Development of biochips for acute myeloid leukemia, brain tumors and myeloma (Kahler’s disease). |
||
Cavadis B.V. Development of diagnostic and therapeutic tools for the treatment |
||
River Diagnostics B.V.Development of medical diagnostic instruments in the field of micro-organism identification and skin composition analysis. |
||
Therosteon B.V.Development of new drug targets for a wide array of bone diseases, including osteoporosis, osteoarthritis, and bone metastasis. |
||
arGen-X B.V.Development of novel, antibody-based medicines with the potential to make a meaningful impact on patients' lives. |